Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 31 Mar 2026 Nový lék na spavou nemoc je přelom. V rozhovoru pro ČT vysvětluje jeho autorka, jak vznikl CT24
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
In the media 20 Mar 2026 Maladie du sommeil: un nouveau traitement laisse entrevoir une élimination de la maladie d’ici à 2030 Media Congo
In the media 17 Mar 2026 Pharmalittle: We’re reading about Trump’s drug pricing moves, a GSK asthma drug, and more STAT
In the media 15 Mar 2026 Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño El Periódico
In the media 15 Mar 2026 Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño Sci Dev Net
In the media 14 Mar 2026 Africa’s one-dose cure brings sleeping sickness elimination within reach The Independent
